Market Overview

Morning Market Gainers

Share:
Related
Mid-Afternoon Market Update: Crude Oil Down 3.5%; AeroVironment Shares Decline On Q1 Results
12 Biggest Mid-Day Losers For Wednesday
Related TMO
Barron's Picks And Pans: Trump Stocks, Thermo Fisher, Discover And More
Earnings Scheduled For October 27, 2016

Atossa Genetics, Inc. (NASDAQ: ATOS) shares jumped 24.13% to $1.48 after the company announced national distribution agreement with Thermo Fisher Scientific (NYSE: TMO).

Quantum Fuel Systems Technologies Worldwide Inc. (NASDAQ: QTWW) shares surged 21.86% to $3.40 after the company reported preliminary Q4 sales of $12 million to $13 million. The company also expected FY15 sales growth in 40% to 50% range.

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) shares surged 13.69% to $24.00 after the company announced the acquisiton of Chinese PLA General Hospital's CAR-T (CD19/CD20/CD30/EGFR) immuno-oncology technology and clinical data.

Achillion Pharmaceuticals, Inc.(NASDAQ: ACHN) shares climbed 13.59% to $12.29 on positive ACH-3102 data.

China Green Agriculture, Inc. (NYSE: CGA) shares rose 13.02% to $2.17. The company's second quarter net sales climbed 33.0% to $54.1million, while net income surged 41.9% to $5.2 million.

Rio Alto Mining Limited (NYSE: RIOM) shares surged 10.22% to $2.91. Tahoe Resources (NYSE: TAOM) announced its plans to acquire Rio Alto Mining in a $1.12 billion cash and stock deal.

Conns Inc. (NASDAQ: CONN) shares gained 8.47% to $24.39. Stifel Nicolaus upgraded Conn's from Hold to Buy.

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) rose 7.38% to $1.31 after the company announced new data on PD-1 and CTLA-4.

Motorola Solutions Inc (NYSE: MSI) shares gained 6.06% to $68.58. Motorola Solutions is considering a sale of the company, according to sources, as reported by Bloomberg.

Hasbro Inc. (NASDAQ: HAS) gained 3.68% to $57.79 after the company reported higher earnings for the fourth quarter and lifted its dividend. The company also announced a $500 million buyback.

Compugen Ltd. (NASDAQ: CGEN) shares rose 2.19% to $7.93 after the company reported new results supporting CGEN-15049 as potential cancer immunotherapy target.

Posted-In: Market GainersNews Intraday Update Markets Movers

 

Related Articles (ACHN + ATOS)

View Comments and Join the Discussion!